MedPath

Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study

Completed
Conditions
Decompressive Craniectomy
Brain Injuries
Treatment Outcome
Registration Number
NCT04682951
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

Decompressive craniectomy is a treatment of refractory intracranial hypertension after various etiologies : malignant ischemic stroke, traumatic brain injury, intraparenchymal hemorrhage, aneurysmal subarachnoid hemorrhage, cerebral venous thrombosis.

Initially considered as a lifesaving therapy, benefits in terms of survival were shown compared to medical treatment alone.

However, despite a better survival, morbidity and poor neurological outcome are frequent among survivors.

The objective of the study is to identify initial good neurological outcome factors after decompressive craniectomy in a large series of patients, in order to argue surgical and intensive care decisions, considering expected benefit and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
544
Inclusion Criteria
  • Patients undergoing a decompressive craniectomy from 06/11/2008 to 06/15/2018 in CHRU Nancy, France.
Exclusion Criteria
  • Infectious ou malignant disease leading to decompressive craniectomy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Good neurological outcome6 months after surgery

The neurological outcome is considered "good" when Glasgow Outcome Score extended (GOSE) assessed 6 months after decompressive craniectomy is between 5 and 8.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Nancy

🇫🇷

Nancy, France

University Hospital of Nancy
🇫🇷Nancy, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.